NEWS & EVENTS
One day, patients may be able to monitor their body's response to cancer therapy just by having their blood drawn. A new study has taken an important step in that direction by measuring a panel of cancer proteins in rare, individual tumor cells that float in the blood. Read more at Science Newsline.
A team of researchers has discovered that damage to collagen, the main building block of all human tissue, can occur much earlier at a molecular level from too much physical stress. This could be especially helpful for some who want to know earlier if they are developing diseases such as arthritis or for athletes who want to know if repeated stress on their bodies is taking a toll. Read more at University of Utah UNEWS.
Researchers have identified a signaling molecule key to the formation of scar tissue surrounding implantable medical devices, a process called fibrosis. Blocking this molecule prevents scar tissue from forming and could help scientists extend the lifespan of many types of implantable medical devices. Read more at MIT News.
Pancreatic cancer has the lowest survival rate among all major cancers, largely because physicians lack diagnostic tools to detect the disease in its early, treatable stages. Now, a team of investigators has developed a promising new tool capable of distinguishing between harmless pancreatic cysts and those with malignant potential with an overall accuracy of 95 percent. Read more form Beth Israel Deaconess Medical Center.
Read more at The Guardian.
A novel technology platform has been developed that enables the continuous and automated monitoring of so-called 'organs-on-chips' -- tiny devices that incorporate living cells to mimic the biology of bona fide human organs. Read more in Science Newsline.
A novel dual-receptor target radiotracer successfully diagnosed prostate cancer at all stages while reducing the number of medical scans a patient normally would have to undergo, according to study results published in The Journal of Nuclear Medicine. Read more at Healio.